Q1 2023 Holdings
Filed 2023-05-10 | 177 holdings | $2.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Amgen Inc.(AMGN) | Common | 031162100 | $134.4M | 555,939 | 5.1% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $129.4M | 1,559,884 | 4.9% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $117.5M | 143,053 | 4.5% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $111.9M | 721,779 | 4.3% |
| Unitedhealth Group Inc.(UNH) | Common | 91324P102 | $110.7M | 234,173 | 4.2% |
| Vertex Pharmaceuticals Inc.(VRTX) | Common | 92532F100 | $104.1M | 330,343 | 4.0% |
| Eli Lilly and Company(LLY) | Common | 532457108 | $99.2M | 288,917 | 3.8% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $81.5M | 511,599 | 3.1% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $80.9M | 348,079 | 3.1% |
| Pfizer Inc.(PFE) | Common | 717081103 | $72.4M | 1,775,076 | 2.8% |
| AstraZeneca PLC(AZN) | Sponsored ADR | 046353108 | $68.9M | 992,664 | 2.6% |
| Biogen Inc.(BIIB) | Common | 09062X103 | $67.0M | 240,926 | 2.6% |
| Abbott Laboratories(ABT) | Common | 002824100 | $63.2M | 623,855 | 2.4% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $58.7M | 552,122 | 2.2% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $54.0M | 93,705 | 2.1% |
| Elevance Health, Inc.(ELV) | Common | 036752103 | $52.5M | 114,070 | 2.0% |
| Moderna, Inc.(MRNA) | Common | 60770K107 | $49.5M | 322,217 | 1.9% |
| The Cigna Group(CI) | Common | 125523100 | $46.7M | 182,631 | 1.8% |
| Bristol-Myers Squibb Company(BMY) | Common | 110122108 | $46.0M | 663,796 | 1.8% |
| Seagen Inc.(SGENUSD) | Common | 81181C104 | $45.5M | 224,663 | 1.7% |
| Sarepta Therapeutics, Inc.(SRPT) | Common | 803607100 | $39.4M | 285,653 | 1.5% |
| argenx SE(ARGX) | Sponsored ADR | 04016X101 | $32.9M | 88,310 | 1.3% |
| Idexx Laboratories, Inc.(IDXX) | Common | 45168D104 | $29.3M | 58,595 | 1.1% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $29.2M | 300,089 | 1.1% |
| Intuitive Surgical, Inc.(ISRG) | Common | 46120E602 | $28.8M | 112,680 | 1.1% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $28.7M | 143,214 | 1.1% |
| Boston Scientific Corp.(BSX) | Common | 101137107 | $28.3M | 565,990 | 1.1% |
| Medtronic plc(MDT) | Shares | G5960L103 | $27.8M | 344,517 | 1.1% |
| Danaher Corp.(DHR) | Common | 235851102 | $26.6M | 105,690 | 1.0% |
| Dexcom, Inc.(DXCM) | Common | 252131107 | $26.6M | 228,747 | 1.0% |
| Charles River Laboratories International, Inc.(CRL) | Common | 159864107 | $23.8M | 118,083 | 0.9% |
| McKesson Corp.(MCK) | Common | 58155Q103 | $23.7M | 66,455 | 0.9% |
| HCA Healthcare, Inc.(HCA) | Common | 40412C101 | $23.4M | 88,703 | 0.9% |
| Zoetis Inc.(ZTS) | Class A | 98978V103 | $22.8M | 136,914 | 0.9% |
| Jazz Pharmaceuticals plc(JAZZ) | Shares | G50871105 | $21.6M | 147,779 | 0.8% |
| Stryker Corp.(SYK) | Common | 863667101 | $20.4M | 71,578 | 0.8% |
| Humana Inc.(HUM) | Common | 444859102 | $17.9M | 36,794 | 0.7% |
| Novo Nordisk A/S(NVO) | Sponsored ADR | 670100205 | $17.7M | 111,323 | 0.7% |
| Molina Healthcare, Inc.(MOH) | Common | 60855R100 | $16.5M | 61,856 | 0.6% |
| ResMed Inc.(RMD) | Common | 761152107 | $16.0M | 73,189 | 0.6% |
| Edwards Lifesciences Corp.(EW) | Common | 28176E108 | $14.2M | 171,146 | 0.5% |
| Exelixis, Inc.(EXEL) | Common | 30161Q104 | $14.1M | 726,639 | 0.5% |
| United Therapeutics Corp.(UTHR) | Common | 91307C102 | $13.7M | 61,200 | 0.5% |
| Acadia Healthcare Company, Inc.(ACHC) | Common | 00404A109 | $13.5M | 186,487 | 0.5% |
| Ascendis Pharma A/S(ASND) | Sponsored ADR | 04351P101 | $13.3M | 123,791 | 0.5% |
| uniQure N.V.(QURE) | Shares | N90064101 | $13.1M | 652,446 | 0.5% |
| Physicians Realty Trust(DOCUSD) | Common | 71943U104 | $13.0M | 873,655 | 0.5% |
| BioNTech SE(BNTX) | Sponsored ADS | 09075V102 | $12.9M | 103,858 | 0.5% |
| Iqvia Holdings Inc.(IQV) | Common | 46266C105 | $12.6M | 63,117 | 0.5% |
| Novartis AG(NVSN) | Sponsored ADR | 66987V109 | $12.5M | 136,225 | 0.5% |